Ignite Creation Date:
2025-12-25 @ 3:11 AM
Ignite Modification Date:
2026-01-23 @ 6:58 AM
Study NCT ID:
NCT01276405
Status:
TERMINATED
Last Update Posted:
2016-11-02
First Post:
2011-01-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Colorectal Cancer | View |
Keywords: